News & Updates
Filter by Specialty:
Show Multimedia Only
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
07 Apr 2022
byRoshini Claire Anthony
Nondiabetic adults with overweight or obesity lost more weight when treated with once-weekly semaglutide than once-daily liraglutide, as demonstrated by results of the phase IIIb STEP* 8 trial.
Semaglutide trumps liraglutide for weight loss in nondiabetic overweight or obese patients
07 Apr 2022
Anaphylaxis after COVID mRNA vaccination relatively rare
06 Apr 2022
byRoshini Claire Anthony
Anaphylactic reactions warranting treatment after receipt of COVID-19 mRNA vaccinations appear to be relatively rare, according to a US study presented at AAAAI 2022.
Anaphylaxis after COVID mRNA vaccination relatively rare
06 Apr 2022
Add-on amantadine lessens “off” episodes in Parkinson’s disease
06 Apr 2022
byJairia Dela Cruz
A delayed release/extended release (DR/ER) formulation of amantadine can help reduce breakthrough symptoms in Parkinson’s disease patients when the effect of levodopa therapy wears off, as shown in a recent study.